Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Clin Lipidol. 2016 Mar 8;10(4):808–815. doi: 10.1016/j.jacl.2016.03.001

Table 3.

Frequency of oxidized and native apoA-II proteoforms

Proteoform Percent of
control
participants
with native
proteoform		 Percent of
diabetic
participants
with native
proteoform		 p-value Percent of
control
participants
with
oxidized
proteoform		 Percent of
diabetic
participants
with
oxidized
proteoform		 p-value
Monomer (M) 100 (25/25) 80 (25/30) 0.03 80 (20/25) 90 (27/30) 0.3
Monomer missing C-terminal glutamine (MQ) 28 (7/25) 33 (10/30) 0.67 92 (23/25) 97 (29/30) 0.45
Monomer missing C-terminal tryptophan and glutamine (MTQ) 52 (13/25) 37 (11/30) 0.04 0 (0/25) 17 (5/30) 0.03
Dimer (D) 96 (24/25) 80 (24/30) 0.08 20 (5/25) 33 (10/30) 0.3
Dimer missing C-terminal glutamine (DQ) 92 (23/25) 80 (24/30) 0.21 16 (4/25) 37 (11/30) 0.09
Dimer missing two C-terminal glutamines (D2Q) 48 (12/25) 23 (7/30) 0.06 4 (1/25) 13 (4/30) 0.23

Percent (frequency). The frequency of native and oxidized proteoforms detected in plama was compared between the diabetic and non-diabetic groups by a Chi-square test.